Circulating Levels of Insulin-Like Growth Factor I (IGF-I) and Risk of Multiple Myeloma: An Observational and Mendelian Randomisation Study

Author(s)

• Yolanda Benavente
• Sara Hermosa
• Nikos Papadimitriou
• Alyssa I. Clay-Gilmour Ph.D., University of South CarolinaFollow
• Elizabeth E. Brown
• Jonathan N. Hofmann
• Nathaniel Rothman
• Qin Lan
• Sonja I. Berndt
• Demetrius Albanes
• Mark Purdue
• Mitchell J. Machiela
• Stephen J. Chanock
• Parveen Bhatti
• Wendy Cozen
• Aaron Norman
• Susan L. Slager
• James R. Cerhan
• Vincent Rajkumar
• Et. Al.

Document Type

Article

Digital Object Identifier (DOI)

https://doi.org/10.1111/bjh.70444

Publication Info

Published in British Journal of Haematology, 2026.

Rights

© 2026 The Author(s). British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

APA Citation

Benavente, Y., Hermosa, S., Papadimitriou, N., Clay‐Gilmour, A., Brown, E. E., Hofmann, J. N., Rothman, N., Lan, Q., Berndt, S. I., Albanes, D., Purdue, M., Machiela, M. J., Chanock, S. J., Bhatti, P., Cozen, W., Norman, A., Slager, S. L., Cerhan, J. R., Rajkumar, V., & Kumar, S. K. (2026). Circulating levels of insulin‐like growth factor I ( IGF ‐I) and risk of multiple myeloma: An observational and Mendelian randomisation study. British Journal of Haematology.https://doi.org/10.1111/bjh.70444